Neuromyotonia as a predictor of tumor recurrence in patients with thymoma-associated myasthenia


  • The occurrence of acquired neuromyotonia (NMT) in thymomatous myasthenia gravis (MG) patients is a rare event that may indicate tumor recurrence.

Why this matters ?

  • These data emphasize the importance of proper tumor vigilance and screening in patients with MG receiving the diagnosis of NMT and vice versa.